Brevan Howard Capital Management LP Supernus Pharmaceuticals, Inc. Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 32,398 shares of SUPN stock, worth $1.05 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
32,398
Previous 7,521
330.77%
Holding current value
$1.05 Million
Previous $271,000
291.51%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SUPN
# of Institutions
306Shares Held
60.8MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$338 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$200 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$169 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$94.3 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$87.7 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.74B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...